Del Poeta et al. reported increased levels of BCL2, BCL-XL and MCL1 expression in AML [23] and Aichberger et al. showed that MCL1 is a BCR-ABL target gene in CML [32]. This evidence concerns the gene BCL2 and acute myeloid leukemia.